Text Size

Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model

This study has been completed.
Sponsor:
Collaborators:
University of California, Davis
USDA Beltsville Human Nutrition Research Center
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00074633
First received: December 17, 2003
Last updated: January 12, 2010
Last verified: January 2010
History of Changes
  Purpose

Increasingly more individuals are trying to lose weight. Indeed, many women, regardless of their size, experience a life-long battle and preoccupation with their weight. Despite the attention to weight and the increase in diet behavior, the incidence of obesity continues to rise. There is little data to show improved long term success for the majority of participants who engage in weight loss behaviors.

The specific aim is to improve the psychological and metabolic health of obese women with a history of chronic dieting through encouraging "Health at Every Size" (HAES). This treatment model emphasizes "intutitive eating," i.e., internal regulation of eating (responding to cues of hunger, appetite and satiety). The HAES model is being compared to the current standard of care in obesity treatment, energy restriction dieting, which encourages cognitive control of eating and weight reduction.


Condition Intervention
Hypercholesterolemia
Hypertension
Depression
Diabetes Mellitus, Type 2
 Behavioral: Health at Every Size (HAES)
Behavioral: Diet (Traditional, moderate energy restriction)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment: 79
Study Start Date: January 2000
  Eligibility

Ages Eligible for Study:   30 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria
  • Caucasian;
  • female;
  • age 30-45 years;
  • Body Mass Index (BMI)>30 m/kg2;
  • non-smoker;
  • not pregnant or lactating;
  • Restraint Scale (Herman and Polivy, 1988) score >15, indicating a history of chronic dieting;
  • no recent myocardial infarction;
  • no active neoplasms, Type 1 diabetes or insulin-dependent Type 2 diabetes, nor history of cerebrovascular or renal disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00074633

Locations
United States, California
Nutrition Department, University of California, Davis
Davis, California, United States, 95616
Western Human Nutrition Research Center
Davis, California, United States, 95616
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of California, Davis
USDA Beltsville Human Nutrition Research Center
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00074633     History of Changes
Other Study ID Numbers: OBFRETTO (completed)
Study First Received: December 17, 2003
Last Updated: January 12, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Type 2 Diabetes
Self-Esteem

Additional relevant MeSH terms:
Depression
Depressive Disorder
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hypercholesterolemia
Hypertension
Obesity
Behavioral Symptoms
Mood Disorders
Mental Disorders
Glucose Metabolism Disorders
Metabolic Diseases
 Endocrine System Diseases
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Vascular Diseases
Cardiovascular Diseases
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013